Showing results (11-20 of 215) with videos related to
Sort By:
Pageof 22
Journal of Translational Medicine|September 5, 2012
TGF-β - an excellent servant but a bad masterLenka Kubiczkova, Lenka Sedlarikova, Roman Hajek, et al.Blood Reviews|September 25, 2020
Selinexor, selective inhibitor of nuclear export: Unselective bullet for blood cancersKaterina Benkova, Jana Mihalyova, Roman Hajek, et al.Expert Review of Hematology|March 3, 2020
Identifying and treating candidates for checkpoint inhibitor therapies in multiple myeloma and lymphomaKatarina Hradska, Michal Kascak, Roman Hajek, et al.British Journal of Haematology|March 6, 2010
Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disordersKarthick R M Raja, Lucie Kovarova, Roman HajekMolecular Biotechnology|August 24, 2010
Proteomic analysis in multiple myeloma researchJana Cumova, Anna Potacova, Zbynek Zdrahal, et al.Leukemia Research|June 26, 2012
Mechanism of immunomodulatory drugs in multiple myelomaLenka Sedlarikova, Lenka Kubiczkova, Sabina Sevcikova, et al.British Journal of Haematology|November 20, 2020
Focus on monoclonal antibodies targeting B-cell maturation antigen (BCMA) in multiple myeloma: update 2021Ivo Demel, Julio Rodriguez Bago, Roman Hajek, et al.Clinical Lymphoma, Myeloma & Leukemia|November 15, 2013
High-risk multiple myeloma: different definitions, different outcomes?Helena Paszekova, Fedor Kryukov, Lenka Kubiczkova, et al.Journal of Cellular and Molecular Medicine|April 10, 2014
Proteasome inhibitors - molecular basis and current perspectives in multiple myelomaLenka Kubiczkova, Ludek Pour, Lenka Sedlarikova, et al.Hematology (Amsterdam, Netherlands)|May 15, 2003
Dendritic cell-based immunotherapy for the treatment of hematological malignanciesTomas Büchler, Jaroslav Michalek, Lucie Kovarova, et al.Pageof 22